4//SEC Filing
Havey Adam 4
Accession 0001367644-23-000013
CIK 0001367644other
Filed
Feb 9, 7:00 PM ET
Accepted
Feb 10, 8:34 PM ET
Size
6.7 KB
Accession
0001367644-23-000013
Insider Transaction Report
Form 4
Havey Adam
EVP, BioDefense Division
Transactions
- Award
Common Stock
2023-02-08+95→ 36,889 total - Tax Payment
Common Stock
2023-02-08$13.25/sh−1,964$26,023→ 34,925 total
Footnotes (2)
- [F1]Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2022 fiscal year, as certified by the Compensation Committee following the performance period. On February 08, 2023, the final certification date, the Compensation Committee certified the achievement of the 2020-2022 PSUs at a payout factor of 101.67% of target resulting in the actual award of 5,792 shares of common stock, which is in excess of the 5,697 shares previously reported on February 25, 2020.
- [F2]Represents shares of common stock withheld to pay taxes.
Documents
Issuer
Emergent BioSolutions Inc.
CIK 0001367644
Entity typeother
Related Parties
1- filerCIK 0001514588
Filing Metadata
- Form type
- 4
- Filed
- Feb 9, 7:00 PM ET
- Accepted
- Feb 10, 8:34 PM ET
- Size
- 6.7 KB